Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus
about
Evaluation of quinolones in experimental animal models of infections.Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.In vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermediusResistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureusCeftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.In vivo antibiotic synergism: contribution of animal models.Fosfomycin: an old, new friend?Quinolone antimicrobial agents: adverse effects and bacterial resistance.Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model.Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin.Assessment of the potential for microbial resistance to topical use of multiple antimicrobial agents.
P2860
Q30446615-31BE1563-D822-4CE9-9D20-8ACBE04B73DDQ33472890-F796317B-FAC2-40EC-AD78-FEF144E92086Q33678216-29BB1E9D-9F83-44C5-9CCA-7C57E278A3F6Q34921154-3E4D5F9A-FCDC-4DF4-B673-870E48AFE5F8Q35253384-E46546AA-AD37-49CC-BE4B-705F8B846338Q35280038-70C4E4D4-1202-4A9F-8C3D-303A439F842BQ35754023-298B8CCB-CAFF-464B-A5B8-8DAD053065DAQ37633415-99AA2E90-B604-42C2-90EE-E9F279923B94Q38322827-01A7DF22-CFD6-48D7-AC59-FE0B397047E8Q38725968-700B6312-C46B-4F44-88C4-1D58701FE715Q40633555-2E21D3FE-CDD7-4125-BDF7-C91A9656BCFAQ41648730-ECDDD34F-D6FF-422C-BDEE-0B8EC6F5D57BQ53846362-F6FE36D9-F65F-4040-A533-E81E1848B77C
P2860
Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@ast
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@en
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@nl
type
label
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@ast
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@en
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@nl
prefLabel
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@ast
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@en
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@nl
P2093
P2860
P356
P1476
Efficacy of pefloxacin-fosfomy ...... esistant Staphylococcus aureus
@en
P2093
J F Lemeland
J P Fillastre
P2860
P304
P356
10.1128/AAC.32.6.919
P407
P577
1988-06-01T00:00:00Z